BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2002
View Archived Issues
Phase III data demonstrate utility of MS-325 for enhancing MRA of vascular occlusive disease
Read More
Novel class of anti-HIV agents under evaluation at Rega Institute
Read More
Viramidine as an effective and safe liver-targeting ribavirin prodrug
Read More
SOD mimetic exerts potent anti-HIV activity and inhibits astrocyte apoptosis
Read More
Nucleoside inhibitors of HIV replication presented in Prague by U.S. university researchers
Read More
Potent analgesic effect demonstrated for duloxetine in an animal model of persistent pain
Read More
Greater global improvement in lipoprotein profiles obtained on new lipid-modifying combination
Read More
Cell death pathways activated by BMS-247550 in refractory ovarian cancer cells
Read More
Cellegy updates 2001 progress and outlook for 2002
Read More
Japanese filing made for sevelamer
Read More
ISTA updates clinical progress of Vitrase
Read More
Genaera highlights key clinical achievements of 2001
Read More
First European country approves Elidel for atopic dermatitis
Read More
WX-UK1 safe and well tolerated in phase Ia trial
Read More
Biovail acquires rights to Teveten in U.S.
Read More
Betaferon therapy shows sustained benefits and tolerability over 12 years
Read More
Comparative study of Thymoglobulin and Simulect in kidney transplant rejection closed early
Read More
Celgene develops new class of SERM with potential as both antiosteoporotic and anticancer agents
Read More
Avidex breakthrough in monoclonal T-cell receptor technology in cancer
Read More
Oxford GlycoSciences progress report
Read More
New antibacterial compounds reported by Aventis
Read More
Lilly describes new series of factor Xa inhibitors
Read More
Bristol-Myers Squibb presents new compounds for the treatment of thrombosis
Read More
FSH receptor agonists for in vitro fertilization patented by Affymax
Read More
Novel contraceptives identified by scientists at Affymax
Read More
PARP inhibitors and their uses presented by Ono
Read More
Fidia's new coumarin derivatives claimed for the treatment of vasculopathies, etc.
Read More